HAUPTMENÜ
AWARDS
Forschergeist gefragt: 14. Novartis Oppenheim-Förderpreis für MS-Forschung ausgelobt
FernstudiumCheck Award: Deutschlands beliebteste Fernhochschule bleibt die SRH Fernhochschule
Vergabe der Wissenschaftspreise der Deutschen Hochdruckliga und der Deutschen Hypertoniestiftung
Den Patientenwillen auf der Intensivstation im Blick: Dr. Anna-Henrikje Seidlein…
Wissenschaft mit Auszeichnung: Herausragende Nachwuchsforscher auf der Jahrestagung der Deutschen…
VERANSTALTUNGEN
Wichtigster Kongress für Lungen- und Beatmungsmedizin ist erfolgreich gestartet
Virtuelle DGHO-Frühjahrstagungsreihe am 22.03. / 29.03. / 26.04.2023: Herausforderungen in…
Pneumologie-Kongress vom 29. März bis 1. April im Congress Center…
Die Hot Topics der Hirnforschung auf dem DGKN-Kongress für Klinische…
Deutscher Schmerz- und Palliativtag 2023 startet am 14.3.
DOC-CHECK LOGIN
Single dose of psychoactive component in cannabis could induce psychotic, depressive, and anxiety symptoms in healthy people
In addition, the review found no consistent evidence that cannabidiol (CBD) moderates the effects of tetrahydrocannabinol (THC – the psychoactive component of cannabis) in healthy volunteers Single dose of THC, roughly equivalent to smoking one joint, may induce a variety of psychiatric symptoms associated with schizophrenia and other psychiatric disorders. These effects are larger
WEITERLESEN »
New coronavirus stable for hours on surfaces
Bethesda, M, USA (March 17, 2020) — The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, according to a new study from National Institutes of Health, CDC, UCLA and Princeton University scientists The New England Journal of Medicine. The scientists found that severe
WEITERLESEN »
Experts stress radiology preparedness for COVID-19
OAK BROOK, Ill., USA (March 16, 2020) – Today, the journal Radiology published the policies and recommendations of a panel of experts on radiology preparedness during the coronavirus disease (COVID-19) public health crisis. The article outlines priorities for handling COVID-19 cases and suggests strategies that radiology departments can implement to contain further infection spread
WEITERLESEN »
Coronavirus-infected patients needing emergency surgery: Anesthesia standards
New Rochelle, NY, USA (March 16, 2020)–Physicians describe the standardized procedure of surgical anesthesia for patients with COVID-19 infection requiring emergency surgery to minimize the risk of virus spread and reduce lung injury in a Letter to the Editor published in Surgical Infections, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. Click here
WEITERLESEN »
Why is appendicitis not always diagnosed in the emergency department?
ANN ARBOR, Mich., USA (March 16, 2020) — While symptoms of appendicitis may be common, a new study suggests that accurately diagnosing the condition in the emergency department may be more challenging. The study, published in JAMA Network Open, highlights that appendicitis is one of the most common surgical emergencies in the United States, but
WEITERLESEN »
Learning empathy as a care giver takes more than experience
Research among nursing students shows that past experience living in poverty or volunteering in impoverished communities, does not sufficiently build empathy towards patients who experience poverty. PHILADELPHIA, USA (March 9, 2020) — Poverty takes a toll on health in many ways. It often causes malnutrition and hunger, creates barriers to access basic resources,
WEITERLESEN »
Being grateful has benefits, but not for these issues: Gratitude interventions don’t help with depression, anxiety
COLUMBUS, Ohio. USA (March 9, 2020) – Go ahead and be grateful for the good things in your life. Just don’t think that a gratitude intervention will help you feel less depressed or anxious. In a new study, researchers at The Ohio State University analyzed results from 27 separate studies that examined the effectiveness
WEITERLESEN »
First study identifies risk factors associated with death in adults hospitalised with new coronavirus disease in Wuhan
(March 9, 2020) — Being of an older age, showing signs of sepsis, and having blood clotting issues when admitted to hospital are key risk factors associated with higher risk of death from the new coronavirus (COVID-19), according to a new observational study of 191 patients with confirmed COVID-19 from two hospitals in Wuhan,
WEITERLESEN »
Hong Kong study shows best practices protect healthcare workers from COVID-19
NEW YORK, USA (March 5, 2020) — Health systems can protect healthcare workers during the COVID-19 outbreak when best practices for infection control are diligently applied along with lessons learned from recent outbreaks, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of
WEITERLESEN »
Improved work environments enhance patient and nurse satisfaction
PHILADELPHIA, USA (March 2, 2020) — Healthcare provider burnout is a mounting public health crisis with up to half of all physicians and one in three nurses reporting high burnout, data show. Burnout rates among nurses also correlate with lower patient satisfaction. While both factors are recognized, little is known about how effective interventions
WEITERLESEN »
30-year study identifies need of disease-modifying therapies for maple syrup urine disease
A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of maple syrup urine disease Strasburg, Pennsylvania. USA (January 24, 2020) — A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse
WEITERLESEN »
Can lithium halt progression of Alzheimer’s disease?
Montreal, Canada (January 24, 2020) — There remains a controversy in scientific circles today regarding the value of lithium therapy in treating Alzheimer’s disease. Much of this stems from the fact that because the information gathered to date has been obtained using a multitude of differential approaches, conditions, formulations, timing and dosages of treatment,
WEITERLESEN »
ICUs receive higher satisfaction scores for end-of-life care than other hospital units
The findings may inform care in other parts of the hospital to improve end-of-life experiences Philadelphia, Pennsylvania, USA (January 23, 2020) — Family caregivers of the deceased rated the quality of end-of-life care in the intensive care unit (ICU) higher than the end-of-life care in other hospital departments (also called wards), according to
WEITERLESEN »
Living near major roads linked to risk of dementia, Parkinson’s, Alzheimer’s and MS
Vancouver, Canada (January 23, 2020) — Living near major roads or highways is linked to higher incidence of dementia, Parkinson’s disease, Alzheimer’s disease and multiple sclerosis (MS), suggests new research published this week in the journal Environmental Health. Researchers from the University of British Columbia analyzed data for 678,000 adults in Metro Vancouver. They
WEITERLESEN »
Urology: Individualized physical therapy reduces incontinence, pain in men after prostate surgery
DALLAS, Texas, USA (Dec. 30, 2019) — For decades, therapy to strengthen pelvic muscles has been the standard treatment for men dealing with urinary incontinence after prostate surgery. But a new study from UT Southwestern’s Departments of Urology and Physical Medicine and Rehabilitation suggests that may not be the best approach. The study examined
WEITERLESEN »
Study shows link to immunotherapy: High BMI may improve cancer survival
Adelaide, South Australia (December 26, 2019) — Above average or high BMI – often linked to cancers, diabetes, cardiovascular and other diseases – may in some cases improve the chance of survival among certain cancers, new research from Flinders University indicates. Focusing on clinical trials of atezolizumab, a common immunotherapy treatment for non-small-cell lung
WEITERLESEN »
Yoga and physical therapy as treatment for chronic lower back pain also improves sleep
BOSTON, Ma, USA — Yoga and physical therapy (PT) are effective approaches to treating co-occurring sleep disturbance and back pain while reducing the need for medication, according to a new study from Boston Medical Center (BMC). Published in the Journal of General Internal Medicine, the research showed significant improvements in sleep quality lasting 52 weeks
WEITERLESEN »
Research summary from the Journal of the American Geriatrics Society: Oral health for older adults
New York, NY, USA (November 8, 2019) — Older adults are at an especially high risk for mouth and tooth infections and the complications that can come with these problems. Losing teeth, which is mainly caused by infection, not only leads to changes in our appearance but may also make it harder to chew
WEITERLESEN »
A game-changing test for Prion, Alzheimer’s and Parkinson’s diseases is on the horizon
Synthetic molecules made at Berkeley Lab can be used to diagnose numerous devastating illnesses Berkeley, Ca, USA (November 6, 2019) — There are currently no effective treatments for prion diseases, a family of fatal neurodegenerative conditions caused by accumulations of misfolded copies of a naturally occurring protein. But now, there is finally an
WEITERLESEN »
Narcissism can lower stress levels and reduce chances of depression
Belfast, UK (October 29, 2019) — People who have grandiose narcissistic traits are more likely to be ‚mentally tough‘, feel less stressed and are less vulnerable to depression, research led by Queen’s University Belfast has found. While narcissism may be viewed by many in society as a negative personality trait, Dr Kostas Papageorgiou, who
WEITERLESEN »
Men with breast cancer face high mortality rates
Nashville, TN, USA (October 22, 2019) — Men with breast cancer are more likely to die than their female counterparts, across all stages of disease, with the disparity persisting even when clinical characteristics, such as cancer types, treatment and access to care are considered, according to a study by Vanderbilt researchers published in JAMA
WEITERLESEN »
FDA approves new breakthrough therapy for cystic fibrosis
Treatment approved for approximately 90% of patients with cystic fibrosis, many of whom had no approved therapeutic options Silver Spring, MD, USA (October 21, 2019) — The U.S. Food and Drug Administration today approved Trikafta (elexacaftor/ivacaftor/tezacaftor), the first triple combination therapy available to treat patients with the most common cystic fibrosis mutation. Trikafta
WEITERLESEN »
Neurosyphilis: Syphilis infection rates in dialysis patients exceed general population
AUGUSTA, Ga., USA (October 15 , 2019) — Syphilis rates, like other sexually transmitted disease rates in the United States, are soaring, and the first known study to examine syphilis rates in patients with kidney failure found an incidence greater than three times that of the general population. Neurosyphilis, in which the brain and
WEITERLESEN »
Researchers use text to measure 200 years of happiness
Reading the past like an open book: Researchers use text to measure 200 years of happiness Coventry, UK (October 14, 2019) — Was there such a thing as ‚the good old days‘ when people were happier? Are current Government policies more or less likely to increase their citizens‘ feelings of wellbeing? Using innovative new
WEITERLESEN »
Study provides insights on treatment and prognosis of male breast cancer
(October 7, 2019) — A recent analysis reveals that treatment of male breast cancer has evolved over the years. In addition, certain patient-, tumor-, and treatment-related factors are linked with better survival. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society. Male breast cancer (MBC) comprises one
WEITERLESEN »
New capsule can orally deliver drugs that usually have to be injected
Coated pill carries microneedles that deliver insulin and other drugs to the lining of the small intestine CAMBRIDGE, MA, USA (October 7, 2019) — Many drugs, especially those made of proteins, cannot be taken orally because they are broken down in the gastrointestinal tract before they can take effect. One example is insulin,
WEITERLESEN »
Crohn’s disease study identifies genetic variant with potential to personalize treatment
The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn’s disease has identified a genetic marker which could individualise drug treatment Exeter, Devon, UK (October 7, 2019) — A UK wide collaboration led by the University of Exeter, Royal Devon & Exeter
WEITERLESEN »
Antipsychotics linked to accumulation of hospital days in persons with Alzheimer’s disease
JOENSUU, KUOPIO, Finland (October 7, 2019) — People with Alzheimer’s disease who used antipsychotic drugs had a higher number of accumulated hospital days than people with Alzheimer’s disease who did not use antipsychotics, according to a new study from the University of Eastern Finland. The results were published in the Journal of American Medical
WEITERLESEN »
How much are you polluting your office air just by existing?
Experiments in a building equipped with thousands of sensors could have answers WEST LAFAYETTE, Ind., USA (October 3, 2019) — Just by breathing or wearing deodorant, you have more influence over your office space than you might think, a growing body of evidence shows. But could these basic acts of existence also be
WEITERLESEN »
Parkinson’s disease is also present in the blood
Aarhus, Denmark (October 3, 2019) — Though Parkinson’s disease is primarily seen as a brain disorder, researchers from Aarhus University, Denmark, have measured that the disease in the blood induces immune-imbalance. This advocates for immune modulation as alternative treatment. The behaviour of immune cells in the blood is so different in patients with Parkinson’s
WEITERLESEN »
FODMAPs diet relieves symptoms of inflammatory bowel disease
London, UK (October 2, 2019) — New research from King’s College London has found that a diet low in fermented carbohydrates has improved certain gut symptoms and improved health-related quality of life for sufferers of inflammatory bowel disease (IBD). New research from King’s College London has found that a diet low in fermented carbohydrates
WEITERLESEN »
Aspirin may prevent air pollution harms
New York, N.Y, USA (October 2, 2019) — A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin may lessen the adverse effects of air pollution exposure on lung function. The team of researchers from the Columbia Mailman School of Public Health, Harvard Chan School of Public Health,
WEITERLESEN »
FDA informs patients, providers and manufacturers about potential cybersecurity vulnerabilities for connected medical devices and health care networks that use certain communication software
Silver Spring, MD, USA (October 1, 2019) — Today, the U.S. Food and Drug Administration is informing patients, health care professionals, IT staff in health care facilities and manufacturers of a set of cybersecurity vulnerabilities, referred to as “URGENT/11,” that—if exploited by a remote attacker—may introduce risks for medical devices and hospital networks. URGENT/11
WEITERLESEN »
Caregivers of people with dementia are losing sleep
Waco, Texas, USA (September 23, 2019) — Caregivers of people with dementia lose between 2.5 to 3.5 hours of sleep weekly due to difficulty falling asleep and staying asleep — a negative for themselves and potentially for those who receive their care, Baylor University researchers say. But the good news is that simple, low-cost
WEITERLESEN »
Commonly used drug for Alzheimer’s disease doubles risk of hospitalization
Ottawa, ON, Canada (September 16, 2019) — A drug commonly used to manage symptoms of Alzheimer disease and other dementias — donepezil — is associated with a two-fold higher risk of hospital admission for rhabdomyolysis, a painful condition of muscle breakdown, compared with several other cholinesterase inhibitors, found a study in CMAJ (Canadian Medical
WEITERLESEN »
FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease
Silver Spring, MD, USA (August 28, 2019) — The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” episodes. An “off” episode is a time when a patient’s medications are not working well, causing an increase in PD
WEITERLESEN »
Depression, anxiety linked to opioid use and reduced survival in women with breast cancer
Charlottesville, VA, USA (August 26, 2019) — Elderly women battling breast cancer who have anxiety, depression or other mental health conditions are more likely to use opioids and more likely to die, a new study led by the University of Virginia School of Medicine suggests. The findings should encourage doctors to better manage mental
WEITERLESEN »
Caregivers of people with dementia are losing sleep
Waco, Texas, USA (August 23, 2019) — Caregivers of people with dementia lose between 2.5 to 3.5 hours of sleep weekly due to difficulty falling asleep and staying asleep — a negative for themselves and potentially for those who receive their care, Baylor University researchers say. But the good news is that simple, low-cost
WEITERLESEN »
Diabetes: Too much of a good thing can be dangerous
ROCHESTER, Minn., USA (August 15, 2019) — For people with diabetes, taking medications and monitoring their blood sugar is part of the rhythm of their daily lives. However, according to new research from Mayo Clinic, more than 20% of adult patients in the U.S. are likely treated too intensively. This has caused thousands of
WEITERLESEN »
Migraine diagnoses positively associated with all-cause dementia
Frankfurt, Germany (August 14, 2019) — Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship. However, most of these studies have failed to simultaneously adjust for several common comorbidities, thus potentially introducing bias into their findings. The goal of the present
WEITERLESEN »
Sleep: Optimistic people sleep better, longer
CHAMPAIGN, Ill., USA (August 7, 2019) — People who are the most optimistic tend to be better sleepers, a study of young and middle-aged adults found. More than 3,500 people ages 32-51 were included in the study sample. The participants included people in Birmingham, Alabama; Oakland, California; Chicago; and Minneapolis. The research was led
WEITERLESEN »
Recarbrio: FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections
Silver Spring, MD, USA (July 17, 2019) — The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI). “The FDA remains focused on facilitating the development of safe and effective new antibacterial drugs
WEITERLESEN »
Is successful HIV therapy a Pyrrhic victory for the brain? HIV may affect the brain despite ongoing antiretroviral therapy
New Haven, CT, USA (July 15, 2019) — HIV-positive patients are living longer, healthier lives thanks to combination antiretroviral therapy (cART), which prevents the virus from replicating and infecting additional cells. However, HIV’s ability to persist in the body despite ongoing cART treatment remains a major obstacle to curing patients. Now, clinical trial results
WEITERLESEN »
Dementia Prevention: Wearing hearing aid may help protect brain in later life
Exeter, UK (July 15, 2019) – A new study has concluded that people who wear a hearing aid for age-related hearing problems maintain better brain function over time than those who do not. It builds on important research in recent years pulled together by the Lancet Commission on Dementia Prevention, Intervention and Care, through
WEITERLESEN »
FDA approves new treatment for pediatric patients with type 2 diabetes
Silver Spring, MD, USA (June 17, 2019) –The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug approved to treat type 2 diabetes in pediatric patients since metformin was approved for pediatric use in
WEITERLESEN »
Drug-resistant infections: If you can’t beat ‚em, starve ‚em, scientists find
Drug-resistant infections: If you can’t beat ‚em, starve ‚em, scientists find Researchers repurpose drug to deny drug-resistant fungus of iron, an element crucial to its survival BUFFALO, N.Y., USA (May 24, 2019) — How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team
WEITERLESEN »
Psychiatry: Study supports effectiveness of new fast-acting antidepressant, esketamine nasal spray
Washington, DC, USA (May 21, 2019) – New research supports the effectiveness and safety of esketamine nasal spray in treating depression in people who have not responded to previous treatment. The research will be published online today in the American Journal of Psychiatry. This study is one of the key studies that led to
WEITERLESEN »
Implementing a care pathway for spatial neglect to improve stroke outcomes
Stroke researchers strive to close the implementation gap for spatial neglect care East Hanover, NJ., USA (May 14, 2019) – Spatial neglect remains a hidden disability despite the availability of effective tools for the diagnosis and treatment for this common complication of stroke. Addressing this implementation gap is critical to reducing disability, improving
WEITERLESEN »
Physical and mental health of seniors linked to optimism, wisdom and loneliness
San Diego, California, USA (May 8, 2019) — Ten thousand Baby Boomers turn 65 every day. By 2029, the entire generation born between 1946 and 1964 will be at least that old. What happens next concerns millions of Americans. Advancing age is broadly associated with declining cognitive, physical and mental health. In a new
WEITERLESEN »
When doctors and nurses can disclose and discuss errors, hospital mortality rates decline
Bocconi, Italy (May 7, 2019) – An association between hospitals‘ openness and mortality rates has been demonstrated for the first time in a study among 137 acute trusts in England, published yesterday in the May issue of Health Affairs. The diffusion of a culture of openness in hospitals is associated with lower hospital mortality,
WEITERLESEN »